uPRAX acquires funding from MIT/Province South Holland for 2019 feasibility study

uPRAX has acquired a grant of 20.000 euro from the Province of South Holland (Provincie Zuid Holland) for part of a feasibility study focused on the necessary user requirements for microneedle applicators. This funding will help uPRAX in the development of a consumer-centric device, to help make microneedle application consistent and reproducible even when they are administered by untrained users. With this research uPRAX will combine these additional user requirements into a product that will make medicine delivery more accessible by higher mobility. With this innovation medicines (like vaccines) could be delivered to the users just by mailing them a small device.